Intratumoral CD103+ DCs traffick to TDLNs by expressing CCR7 to prime naive CD8+ T cells, causing tumor-specific CD8+ T cells to increase in number and infiltrate tumors5. The gene discussed is CD8A; the disease is neoplasm.